InsideRadio.com reported pharmaceutical companies have ramped up their advertising on network radio, with drug stores and pharmaceutical firms investing $150.9m in the medium for 2022, according to MillerKaplan.
The pharmaceutical segment accounted for $146.3m, up 14.1% year-over-year, while spending by drug stores plummeted 50.7% to $4.6m.
The rise was driven by companies including Pfizer, which spent $62m on network radio in 2022.
Advancements in targeting and supply-side products have made radio a more efficient channel for pharmaceutical advertisers.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.